Physician profile
William H Harvin
NPI 1356651301
$184,781.53
in general payments reported to CMS, 2019-2025
22 companies · $82K in 2025
The $82K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,379 · 2020: $613 · 2021: $693 · 2022: $23K · 2023: $35K · 2024: $38K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $99K · Honoraria: $20K · Travel and Lodging: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $6,483 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,954.60 |
| Honoraria | $20,000.00 |
| Travel and Lodging | $14,219.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,943.00 |
| Food and Beverage | $6,483.05 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $84,618.51 | 2021-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Zimmer Biomet Holdings, INC. | $43,864.63 | 2019-2025 | Affixus |
| Curvafix, INC. | $21,687.67 | 2023-2025 | Curvafix Im Implant |
| Medical Device Business Services, INC. | $14,123.86 | 2022-2025 | Fibergraft Aeridyan Matrix |
| Synthes Gmbh | $7,479.12 | 2019-2023 | |
| Bonebridge INC. | $4,604.60 | 2025 | |
| Depuy Synthes Sales INC. | $1,865.63 | 2019-2025 | Na, Fibergraft Bg Morsels, Fibergraft Aeridyan Matrix |
| Medinc of Texas | $1,845.71 | 2022-2025 | |
| Arthrex, INC. | $1,395.57 | 2025 | |
| Stryker Corporation | $1,211.69 | 2019-2025 | Gravity Synchfix, Pangea, Gamma |
| Alafair Biosciences, INC. | $489.95 | 2023 | Versawrap |
| Osteocentric Technologies, INC. | $478.22 | 2019-2021 | |
| Royal Biologics, INC. | $288.69 | 2025 | |
| Medtronic, INC. | $182.71 | 2023 | Swiftset, Polysorb |
| Globus Medical, INC. | $159.36 | 2024 | Proximal Tibia Plate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive Specialized Orthopedics, INC. | $146.21 | 2020 | |
| Skeletal Dynamics INC | $142.36 | 2021-2024 | Ijs, Geminus, Align |
| Smith+Nephew, INC. | $106.68 | 2019 | |
| Acera Surgical, INC. | $44.37 | 2023 | Restrata Wound Matrix |
| Ethicon US, LLC | $23.88 | 2025 | Ethicon, Stratafix, Evarrest |
| Biotissue Holdings INC. | $12.50 | 2022 | |
| Ermi LLC | $9.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Harvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.